`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`RANBAXY LABORATORIES LTD and RANBAXY, INC.,
`
`Petitioners
`
`ADAMAS PHARMACEUTICALS, INC.,
`
`Patent Owner
`
`Inter Pam’s Review No.: 2015-00410
`
`US. Patent No. 8,362,085
`
`PETITIONERS’ POWER OF ATTORNEY
`
`
`
`PETITIONER POWER OF ATTORNEY '
`
`Petitioners, Ranbaxy Laboratories Ltd. and Ranbaxy, Inc, hereby appoint
`
`practitioners associated with Kenyon & Kenyon LLP, Customer Number 26,646,
`
`including the following lead and backup counsel:
`
`
`
`
`
` Lead Counsel Back-up Counsel
`
`John W. Bateman
`Anne Elise Herold Li
`(Reg. No. 41,602)
`(Reg. No. 53,181)
`KENYON & KENYON LLP KENYON & KENYON LLP
`
`
`
`
`
`One Broadway
`New York, NY 10004—1007
`ali@kenyon.com
`Tel: 212.908.6083
`
`Fax: 212.425.5288
`
`1500 K Street, NW
`Washington, DC 20005
`jbateman@kenyon.com
`Tel: 202.220.4216
`
`FaX: 202.220.4201
`
`
`
`as its attorneys to prosecute the inter partes review proceeding relating to US.
`
`Patent 8,262,085 and to transact all business in the United States Patent and
`
`Trademark Office associated with an inter partes review of US. Patent
`
`No. 8,262,085.
`
`The undersigned is empowered to act on behalf of Petitioner.
`
`RANBAXY LABORATORIES LTD and RANBAXY, INC.
`
`m g A
`Name: Kathryn Jones
`Title: Director, Intellectual Property
`Date: December 17, 2014
`
`